Veeva Systems (NYSE:VEEV) Updates FY 2027 Earnings Guidance

Veeva Systems (NYSE:VEEV) updated its FY 2027 earnings guidance on Wednesday. The company provided earnings per share guidance of 9.050-9.050 for the period, compared to the consensus earnings per share estimate of 8.370. The company issued revenue guidance of $3.6 billion-$3.6 billion, compared to the consensus revenue estimate of $3.6 billion. Veeva Systems also updated its Q2 2027 guidance to 2.210-2.220 EPS.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. TD Cowen cut their price objective on Veeva Systems from $380.00 to $300.00 and set a “buy” rating for the company in a report on Thursday, March 5th. Royal Bank Of Canada cut their price objective on Veeva Systems from $330.00 to $275.00 and set an “outperform” rating for the company in a report on Thursday, March 5th. Morgan Stanley lifted their price objective on Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a report on Thursday, March 5th. Canaccord Genuity Group cut their price objective on Veeva Systems from $280.00 to $235.00 and set a “hold” rating for the company in a report on Thursday, March 5th. Finally, Wall Street Zen lowered Veeva Systems from a “buy” rating to a “hold” rating in a report on Sunday, March 22nd. Seventeen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Veeva Systems has a consensus rating of “Moderate Buy” and an average price target of $271.52.

Veeva Systems Stock Down 2.3%

Shares of Veeva Systems stock opened at $178.69 on Thursday. The stock’s 50-day simple moving average is $166.29 and its 200-day simple moving average is $196.71. Veeva Systems has a 52 week low of $148.05 and a 52 week high of $310.50. The company has a market capitalization of $29.19 billion, a price-to-earnings ratio of 33.03, a PEG ratio of 0.81 and a beta of 0.95.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The business had revenue of $882.95 million for the quarter, compared to the consensus estimate of $857.73 million. During the same period in the previous year, the business earned $1.97 earnings per share. The business’s revenue was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, equities analysts expect that Veeva Systems will post 6.45 earnings per share for the current year.

Insider Activity at Veeva Systems

In other news, Director Priscilla Hung sold 750 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the transaction, the director directly owned 3,253 shares in the company, valued at $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by insiders.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported Q1 revenue of about $882.9 million and adjusted EPS of $2.24, both ahead of estimates, showing continued demand and profitability improvement. Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management issued Q2 revenue guidance of roughly $902 million-$905 million and EPS guidance of $2.21-$2.22, both above consensus, signaling confidence in near-term growth. Veeva Announces Fiscal 2027 First Quarter Results
• Positive Sentiment: Veeva highlighted AI innovations during the earnings call, which may support future product adoption and help the company deepen its competitive position in life sciences software. Veeva Systems Inc (VEEV) Q1 2027 Earnings Call Highlights: Surpassing Revenue Guidance and Unveiling AI Innovations
• Neutral Sentiment: Several summaries of the results emphasized that the quarter’s headline numbers were strong, but investors are still parsing the full transcript and details behind the outlook. Veeva Systems Inc. (VEEV) Q1 2027 Earnings Call Transcript
• Negative Sentiment: Despite the beat-and-raise report, some coverage noted the shares slipped after the announcement, suggesting the market may have been positioned for strong results or is focused on valuation and broader market sentiment. Veeva Shares Slip Despite Beating Q1 Estimates: Details

Hedge Funds Weigh In On Veeva Systems

Several large investors have recently made changes to their positions in VEEV. Sivia Capital Partners LLC lifted its position in shares of Veeva Systems by 225.9% in the second quarter. Sivia Capital Partners LLC now owns 3,122 shares of the technology company’s stock worth $899,000 after buying an additional 2,164 shares in the last quarter. Equity Wealth Partners LLC purchased a new stake in shares of Veeva Systems in the third quarter worth about $232,000. Epoch Investment Partners Inc. purchased a new stake in shares of Veeva Systems in the third quarter worth about $225,000. Brown Brothers Harriman & Co. lifted its position in shares of Veeva Systems by 8.1% in the third quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company’s stock worth $214,000 after buying an additional 54 shares in the last quarter. Finally, L2 Asset Management LLC purchased a new stake in shares of Veeva Systems in the third quarter worth about $210,000. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.